James P. Moriarty

3.8k total citations · 1 hit paper
99 papers, 2.6k citations indexed

About

James P. Moriarty is a scholar working on Surgery, Economics and Econometrics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, James P. Moriarty has authored 99 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Surgery, 20 papers in Economics and Econometrics and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in James P. Moriarty's work include Healthcare Policy and Management (10 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Cardiac, Anesthesia and Surgical Outcomes (7 papers). James P. Moriarty is often cited by papers focused on Healthcare Policy and Management (10 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Cardiac, Anesthesia and Surgical Outcomes (7 papers). James P. Moriarty collaborates with scholars based in United States, Canada and United Kingdom. James P. Moriarty's co-authors include Bijan J. Borah, Nilay D. Shah, Robin Patel, Jayawant N. Mandrekar, James M. Steckelberg, Christine B. Teng, Scott A. Cunningham, Ritu Banerjee, Sherry M. Ihde and James M. Naessens and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

James P. Moriarty

93 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Trial of Rapid Multiplex Polymerase Chain Reaction–Based Blood Culture Identification and Susceptibility Testing

2015 390 citations James P. Moriarty, Nilay D. Shah et al. profile →

Peers

Countries citing papers authored by James P. Moriarty

Since Specialization

Citations

This map shows the geographic impact of James P. Moriarty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James P. Moriarty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James P. Moriarty more than expected).

Fields of papers citing papers by James P. Moriarty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James P. Moriarty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James P. Moriarty. The network helps show where James P. Moriarty may publish in the future.

Co-authorship network of co-authors of James P. Moriarty

This figure shows the co-authorship network connecting the top 25 collaborators of James P. Moriarty. A scholar is included among the top collaborators of James P. Moriarty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James P. Moriarty. James P. Moriarty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cost analysis of CYP2C19 genetic testing in percutaneous coronary intervention patients 2024 ·The Pharmacogenomics Journal ·(unknown), James P. Moriarty, Mark A. Hlatky, Ryan J. Lennon, Kent R. Bailey, Malcolm R. Bell, Nancy L. Geller, Amir Lerman, Verghese Mathew, Yves Rosenberg, Michael E. Farkouh, Charanjit S. Rihal, Bijan J. Borah, Naveen L. Pereira	0
2	Yttrium-90 Ibritumomab Tiuxetan is Cost-Effective Compared to Bendamustine + Rituximab in Low-grade Lymphomas 2023 ·Clinical Lymphoma Myeloma & Leukemia ·Muhamad Alhaj Moustafa, Bijan J. Borah, James P. Moriarty, (unknown), Liuyan Jiang, (unknown), Thomas E. Witzig, Bradford S. Hoppe, Jennifer Peterson, James R. Cerhan, Han W. Tun	1
3	Evaluating the cost-effectiveness of testing pregnant women for penicillin allergy 2023 ·PLoS ONE ·Viengneesee Thao, Emily E. Sharpe, (unknown), (unknown), James P. Moriarty, Bijan J. Borah, (unknown), Regan N. Theiler	2
4	Comparative cost‐effectiveness of neoadjuvant chemotherapy regimens for muscle‐invasive bladder cancer: Results according to VESPER data 2022 ·Cancer ·Daniel Joyce, Kevin Wymer, Vidit Sharma, James P. Moriarty, Bijan J. Borah, Daniel M. Geynisman, Elizabeth R. Plimack, Brian A. Costello, Lance C. Pagliaro, Stephen A. Boorjian	9
5	Modeling the Cost of Teleneonatology from the Health System Perspective 2022 ·Telemedicine Journal and e-Health ·Viengneesee Thao, (unknown), (unknown), James P. Moriarty, Christopher E. Colby, Bart M. Demaerschalk, Bijan J. Borah, Jennifer L. Fang	2
6	Cost-effectiveness of the anti-fibrotics for the treatment of idiopathic pulmonary fibrosis in the United States 2022 ·BMC Pulmonary Medicine ·Timothy Dempsey, Viengneesee Thao, James P. Moriarty, Bijan J. Borah, Andrew H. Limper	15
7	Artificial intelligence-assisted clinical decision support for childhood asthma management: A randomized clinical trial 2021 ·PLoS ONE ·Hee Yun Seol, Pragya Shrestha, (unknown), Chung‐Il Wi, Sunghwan Sohn, Euijung Ryu, Miguel Park, (unknown), Sungrim Moon, Katherine S. King, Philip H. Wheeler, Bijan J. Borah, James P. Moriarty, Jordan K. Rosedahl, Hongfang Liu, (unknown), Young J. Juhn	46
8	Cost-Effectiveness of Multitarget Stool DNA Testing vs Colonoscopy or Fecal Immunochemical Testing for Colorectal Cancer Screening in Alaska Native People 2021 ·Mayo Clinic Proceedings ·Diana Redwood, Tuan Dinh, John B. Kisiel, Bijan J. Borah, James P. Moriarty, Ellen Provost, Frank Sacco, James Tiesinga, David A. Ahlquist	22
9	A model-based cost-effectiveness analysis of pharmacogenomic panel testing in cardiovascular disease management: preemptive, reactive, or none? 2020 ·Genetics in Medicine ·Ye Zhu, James P. Moriarty, Kristi M. Swanson, Paul Y. Takahashi, Suzette J. Bielinski, Richard Weinshilboum, Liewei Wang, Bijan J. Borah	37
10	Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis with Severe Kidney Disease 2020 ·Journal of the American Society of Nephrology ·Marta Casal Moura, María V. Irazabal, Alfonso Eirin, Ladan Zand, Sanjeev Sethi, Bijan J. Borah, Jeffrey L. Winters, James P. Moriarty, Rodrigo Cartin‐Ceba, Alvise Berti, Misbah Baqir, (unknown), Ashima Makol, Kenneth J. Warrington, Viengneesee Thao, Ulrich Specks, Fernando C. Fervenza	49
11	Health Economic Analysis of Postoperative Video Telemedicine Visits to Patients' Homes 2020 ·Telemedicine Journal and e-Health ·Bart M. Demaerschalk, Stephen D. Cassivi, (unknown), Bijan J. Borah, James P. Moriarty, Rachel E. Gullerud, Sarvam P. TerKonda	28
12	Understanding Failure to Rescue After Esophagectomy in the United States 2019 ·The Annals of Thoracic Surgery ·Zaid M. Abdelsattar, Elizabeth B. Habermann, Bijan J. Borah, James P. Moriarty, (unknown), Shanda H. Blackmon	39
13	FIRSTT study: randomized controlled trial of uterine artery embolization vs focused ultrasound surgery 2018 ·American Journal of Obstetrics and Gynecology ·Shannon K. Laughlin-Tommaso, (unknown), Ahmed M. Abdelmagied, Lisa E. Vaughan, Amy L. Weaver, Gina K. Hesley, David A. Woodrum, Vanessa L. Jacoby, Maureen P. Kohi, Thomas M Price, (unknown), Michael J. Miller, Bijan J. Borah, James P. Moriarty, Krzysztof R. Gorny, Phyllis C. Leppert, (unknown), Maureen A. Lemens, Elizabeth A. Stewart	64
14	An integrated digital/clinical approach to smoking cessation in lung cancer screening: study protocol for a randomized controlled trial 2017 ·Trials ·Amanda L. Graham, Michael V. Burke, Megan A Jacobs, Sarah Cha, Ivana T. Croghan, Darrell R. Schroeder, James P. Moriarty, Bijan J. Borah, (unknown), (unknown), (unknown), David E. Midthun, J. Taylor Hays	6
15	Disparities in Surgical Care Among Women With Endometrial Cancer 2016 ·Obstetrics and Gynecology ·(unknown), Rayna K. Matsuno, James P. Moriarty, Bijan J. Borah, Sean C. Dowdy, Edward J. Tanner, Martin A. Makary, Rebecca L. Stone, Kimberly Levinson, Sarah M. Temkin, Amanda N. Fader	34
16	Cost-Effectiveness of Proton Beam Therapy for Intraocular Melanoma 2015 ·PLoS ONE ·James P. Moriarty, Bijan J. Borah, Robert L. Foote, José S. Pulido, Nilay D. Shah	21
17	The Effects of Incremental Costs of Smoking and Obesity on Health Care Costs Among Adults 2012 ·Journal of Occupational and Environmental Medicine ·James P. Moriarty, Megan E. Branda, Kerry D. Olsen, Nilay D. Shah, Bijan J. Borah, Amy E. Wagie, Jason S. Egginton, James M. Naessens	46
18	Prevalence, management and outcomes of traumatic brain injury patients admitted to an Irish intensive care unit 2011 ·Irish Journal of Medical Science (1971 -) ·Stephen Fröhlich, (unknown), James P. Moriarty	9
19	Sacral Tumor Resection 2011 ·Spine ·Michael Brown, Daryl J. Kor, Timothy B. Curry, Matthew A. Warner, (unknown), Steven H. Rose, Mark B. Dekutoski, James P. Moriarty, Kirsten Hall Long, Peter S. Rose	23
20	Cost Modeling of Preoperative Axillary Ultrasound and Fine-Needle Aspiration to Guide Surgery for Invasive Breast Cancer 2010 ·Annals of Surgical Oncology ·Judy C. Boughey, James P. Moriarty, Amy C. Degnim, (unknown), Jason S. Egginton, Kirsten Hall Long	65

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact